BOVZUTA Trademark

Trademark Overview

On Wednesday, August 26, 2009, a trademark application was filed for BOVZUTA with the United States Patent and Trademark Office. The USPTO has given the BOVZUTA trademark a serial number of 77813372. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 5, 2018. This trademark is owned by Wyeth. The BOVZUTA trademark is filed in the Pharmaceutical Products category with the following description:

Oncology pharmaceutical preparations
bovzuta

General Information

Serial Number77813372
Word MarkBOVZUTA
Filing DateWednesday, August 26, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 5, 2018
Registration Number3971235
Registration DateTuesday, May 31, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2010

Trademark Statements

Goods and ServicesOncology pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 5, 2018
Primary Code005
First Use Anywhere DateThursday, February 10, 2011
First Use In Commerce DateThursday, February 10, 2011

Trademark Owner History

Party NameWYETH LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWYETH LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMADISON, NJ 07940
Party NameWYETH LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMADISON, NJ 07940
Party NameWyeth
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMadison, NJ 07940
Party NameWyeth
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMadison, NJ 07940

Trademark Events

Event DateEvent Description
Friday, January 5, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, May 31, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 6, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 6, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 23, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 31, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, April 27, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 26, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, April 26, 2011ASSIGNED TO LIE
Tuesday, April 12, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 11, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, April 1, 2011USE AMENDMENT FILED
Friday, April 1, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, March 30, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2010EXTENSION 1 GRANTED
Tuesday, October 5, 2010EXTENSION 1 FILED
Thursday, October 21, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 5, 2010TEAS EXTENSION RECEIVED
Wednesday, June 23, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 21, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2010PUBLISHED FOR OPPOSITION
Friday, December 4, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 4, 2009ASSIGNED TO LIE
Tuesday, November 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2009ASSIGNED TO EXAMINER
Wednesday, September 2, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 1, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

bovzuta preparations pharmaceutical oncology